{
    "2018-03-21": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Novartis Signs Agreement With Canadian Cannabis Company Tilray Regarding Med Pot",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Agreement",
                        "Canadian",
                        "Cannabis",
                        "Tilray",
                        "Med Pot"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Teva Sued by Corcept Therapeutics over Patent Infringement Claim",
                "features": {
                    "keywords": [
                        "Teva",
                        "Sued",
                        "Corcept",
                        "Therapeutics",
                        "Patent",
                        "Infringement"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Latest Stock Recommendations on TEVA: Mostly ‘Holds’",
                "features": {
                    "keywords": [
                        "Stock",
                        "Recommendations",
                        "TEVA",
                        "Holds"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Notable ETF Inflow Detected - VEU, NSRGY, VIS, NVS",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "VEU",
                        "NSRGY",
                        "VIS",
                        "NVS"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "global equities",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "A Look at Akcea Therapeutics’ Product Pipeline",
                "features": {
                    "keywords": [
                        "Akcea",
                        "Therapeutics",
                        "Product",
                        "Pipeline"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Exploring Akcea Therapeutics’ Cash Flows",
                "features": {
                    "keywords": [
                        "Akcea",
                        "Therapeutics",
                        "Cash",
                        "Flows"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "GlaxoSmithKline Prescribes Commercial Reboot for Pharma Division",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Commercial",
                        "Reboot",
                        "Pharma"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Swiss Stock Market Dropped On Weakness Of Bank Stocks",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Dropped",
                        "Weakness",
                        "Bank",
                        "Stocks"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "banking"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.",
                "features": {
                    "keywords": [
                        "Better",
                        "Buy",
                        "Amgen",
                        "Inc.",
                        "Gilead",
                        "Sciences"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Regeneron Eylea Hits 24-Week Primary Endpoint in Study",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Eylea",
                        "Hits",
                        "24-Week",
                        "Primary",
                        "Endpoint",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}